Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
Effective, holistic, science-backed targeted solutions for symptomatic treatment
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
Subscribe To Our Newsletter & Stay Updated
